A record of what Jefferies Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“Maintains a 'Hold' rating on Divi's Laboratories with a price target of ₹6,200. The company's Q4 numbers were in line with estimates, showing balanced growth. However, near-term patent challenges and a high valuation of 51x FY27 estimated earnings limit upside potential.”
Jefferies Analysis’s track record (trackable calls only): 153 graded calls · 95% CI 37–53%
Divi's LaboratoriesNeutralCalled 19 May 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Jefferies Analysis’s full track record